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Introduction
Aging is the underlying mechanism of atherosclerotic arterial disease 
and the elderly population constitutes a rapidly increasing subgroup of 
patients presenting with ischemic heart disease (IHD) [1]. 
The prevalence of cardiovascular disease (CVD), including coronary 
heart disease, heart failure, stroke, and hypertension in men and women 80 
years of age and older has been reported at 84.7% and 85.9%, respectively 
[2]. Compared with younger counterparts, obstructive coronary artery 
disease (CAD) is often more diffuse and severe anatomically in the elderly 
population. Such complex anatomy along with the large territory of 
jeopardized myocardium makes the choice of optimal treatment strategy 
pivotal for risk reduction. In this context, the recent temporal trend shows 
declining in mortality along with an increase in myocardial reperfusion 
rate [2]. Despite that, as compared with men, women maintain a worse 
outcome. This female susceptibility, irrespective of less extent of coronary 
atherosclerotic involvement, seems to be mainly related to the older age 
Abstract 
Background: Women with ischemic heart disease (IHD) typically present less severe coronary artery atherosclerosis. Despite that, as 
compared with men, women maintain a worse outcome. This female susceptibility seems to be mainly related to older age of clinical presentation 
and heavier risk factors burden. 
Purpose: To investigate whether sex differences exist in the real-world management and clinical outcome of elderly patients with suspected IHD.
Methods: Retrospective analysis of IHD elderly (≥ 80 years) patients undergoing coronary angiography for acute coronary syndrome (ACS) or 
stable angina (SA). Management strategy, including invasive revascularization or a conservative medical approach, and outcome were evaluated.
Results: A total of 1420 (41% women; mean age: 83.1 ± 2.8) IHD patients referring for ACS (43%) and SA (57%) were analyzed. Men more 
likely accessed for SA (59.6% vs 52.5%, p<0.001) whereas ACS was the most frequent reason for angiography in women (28.8% vs 21.5%, 
p<0.001). No significant sex differences in the burden of obstructive epicardial disease were observed in both ACS and SA patients. No sex 
disparities in antiplatelet therapy, specifically clopidogrel, were detected. Compared with SA men patients, female ones received more likely a 
conservative therapy (p=0.049). After a median (IQR) follow-up time of 39.0 (16-71) months, a total of 514 (36%) patients died. No sex differences 
in cardiac death (p=0.139) was observed. Nevertheless, the Kaplan Meier curves showed a trend in lower all-cause mortality in female group 
(p=0.093).
Conclusions: In the very elderly population, an invasive strategy is superior to a conservative one in terms of survival rate. However, a dilution 
of the efficacy occurs with increasing age and comorbidities, and for male patients the benefit of the invasive strategy is not clear. Prospective 
studies are warranted to evaluate the net benefit of an invasive or a conservative approach in older population.
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of clinical presentation, mainly with atypical symptoms, and heavier risk 
factors burden [3,4].
To date, data from trials exclusively enrolling elderly patients are scarce 
and the management of elderly patients with IHD is essentially addressed 
by subgroup analyses from major trials. Furthermore, the proportion of 
such patients in ACS clinical trials is much lower (10%) than that seen in 
everyday clinical practice, where around 35% of ACS patients are aged ≥ 
75 years [5]. As a consequence, a significant knowledge gap persists and 
the treatment opportunities may be underappreciated. Moreover, few 
data from randomized trials have addressed the question of the existence 
of gender difference in affecting management and outcomes in the very 
elderly population.
The aim of the present analysis is to investigate whether sex differences 
exist in the management of unselected population with suspected CAD, 
aged 80 years or older, undergoing diagnostic coronary angiography 
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as invasive therapy strategy. Moreover, we assessed the independent 
predictors of all-cause mortality and cardiac mortality in this peculiar 
cohort of frail patients.
Methods
Study population
From January 2004 to January 2011, 1420 out of 2350 consecutive 
patients with suspected CAD, aged 80 years or older, undergoing 
diagnostic coronary angiography followed by elective procedures or 
primary interventions coronary procedure were considered for the 
enrollment in the present analysis. The complete availability of clinical 
and angiographic records was mandatory for the inclusion of patients 
in the analysis. Patients were recruited from the Department of the 
Heart and Great Vessels Attilio Reale, SAPIENZA-University of Rome 
and Department of Interventional Cardiology, Santa Maria University 
Hospital, Terni.
Octogenarians patients accessed to the catheterization lab for acute 
coronary syndrome (ACS) or stable angina (SA). The revascularization 
strategy, conservative or invasive, was determined by interventional 
cardiologists and cardiac surgeons, on the basis of hemodynamic 
conditions, lesion characteristics, vessel size, the presence of co-
morbidities, quality of arterial and/or venous conduits for grafting, 
and patient and/or referring physician preferences. In all cases, the 
selected revascularization approach (i.e. angioplasty with or without 
stent implantation and coronary artery bypass graft) seemed suitable to 
guarantee complete revascularization.
Clinical, anthropometric, angiographic and procedural data were 
collected in each patient at the moment of the diagnostic angiography. 
Information with regard to the clinical status at the latest clinical follow-
up available was collected by clinical visits, telephone interviews or 
referring physicians. Cardiovascular risk factors were defined as follows: 
hypertension, diabetes mellitus, and/or dyslipidemia [6]. Family 
history was considered significant, if a first-degree relative younger 
than 55-year-old (male) or 65-year-old (female) suffered premature 
CVD [6].
Pharmacological therapy at baseline was optimized according to 
guidelines for antihypertensive agents, antithrombotics and statins 
treatment. In particular, antiplatelet therapy was administered according 
to revascularization strategy and to the type of stent implanted. Both 
hypertension and dyslipidemia were categorized as treated conditions.
Myocardial infarction was defined based on the definition extracted 
from Thygesen et al. [7]. ST-segment elevation myocardial infarction 
(STEMI) was defined as ST-segment elevation or left bundle branch 
block on initial ECG and elevation of cardiac markers. Non-ST-segment 
elevation myocardial infarction (NSTEMI) was defined in case of angina 
symptoms and/or ECG changes and elevated cardiac markers. Unstable 
angina (UA) was diagnosed in presence of angina symptoms and/or ECG 
changes and normal values of cardiac markers. On the other hand, stable 
angina was defined in presence of angina symptoms with stress tests 
inducible myocardial ischemia.
During follow-up observation, major adverse outcomes were defined. 
Death was classified as cardiac when it resulted from an acute myocardial 
infarction, sudden death, and death due to heart failure.
All-cause death included all death events occurred during follow-up. 
Cardiac and overall death was analyzed cumulatively at latest clinical 
follow-up available. All events were recorded and adjudicated by two 
blinded cardiologists (MD and AA).
Statistics
Continuous variables were reported as mean ± SD or as median and 
interquartile range (IQR) as appropriate. Comparisons between groups of 
continuous variables were performed by t-test or Mann-Whitney U test. 
Categorical variables, reported as counts and percentages, were compared 
by Chi-square test or Fisher’s exact test when cell count was less than five.
Cumulative event curves were generated with the Kaplan-Meier 
method. Log-rank test was performed to analyze differences in survival 
distributors between subgroups. Univariate and multivariate Cox models 
were used to assess clinically relevant factors’ effect on the endpoints. The 
Cox proportional hazards regression model included all variables with a 
p<0.10. A forward stepwise model selection procedure based on the AIC 
was used to select the best multivariate regression model.
A two-sided p value <0.05 was considered as statistically significant. All 
analyses were performed using SPSS v. 22 (IBM, NY, USA).
Results
One-thousand-four-hundred-twenty patients (59% men) undergoing 
percutaneous coronary intervention (PCI) were analyzed. In the 43% 
(n=615) of cases, ACS was the reason for PCI, while eight-hundred-five 
patients were studied for stable angina.
Table 1 reported the clinical characteristics of octogenarians at baseline 
according to sex. Women undergoing PCI were significantly older, with 
a low BSA, more frequently affected by hypertension, diabetes, and 
dyslipidemia comparing to men. In the 9% of cases, females’ patients had 
a concomitant cardiac valvular disease. For women, NSTEMI or STEMI 
were the more frequent reasons for undergoing angiography comparing 
with men that reported more often stable angina. Women with STEMI 
underwent to primary PCI more frequently than men. Moreover, in 
the case of UA and NSTEMI, women were more frequently undergone 
elective angiography comparing with men.
When the study population was split according to the presence of ACS, 
sex gender disparities persist.
Angiographic data are reported in table 2 for ACS patients and in 
table 3 for SA.
Clinical outcomes during follow-up
Survival analysis: After a median [IQR] follow-up time of 39.0 (IQR: 
16-71) months a total of 514 (36%) patients died: 24 (2.2%) cardiac deaths, 
54 (5.0%) all-cause death events were recorded. Table 4 reports baseline 
demographic and clinical characteristics of patients who experience the 
clinical outcomes.
No differences in mortality were found according to sex. Significantly 
higher rates of all events considered were found for patients receiving 
femoral vascular access, diabetics, with chronic kidney disease, with a 
three-vessel disease, presenting with an ACS and with a previous history 
of MI. Survived patients had more commonly treated hypertension, 
treated dyslipidemia, stable angina, a lower coronary impairment.
No sex differences in all-cause mortality and cardiac death were 
observed along the follow-up. Nevertheless, the KM curves showed a 
trend in better prognosis in female group (Figure 1).
Kaplan-Meier curves analysis showed that very elderly patients had 
a higher risk for occurrence of cardiac death (Log-rank: 7.91, p=0.005), 
and all-cause death (Log-rank: 5.51, p<0.001) compared to patients 
with less than 85 years old (Figures 2 and 3, Panels A-B). This difference 
persists even when the survival analysis was adjusted for revascularization 
strategy (Log-rank=5,379, p=0.02 and Log-rank=7,573, p=0.006 for all-
cause death and cardiac death respectively) (Data not shown).
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Epicardial Coronary Angiographic Data
Normal or non epicardial occlusive 
disease 22 (6.5) 28 (10.1)
0.055One-vessel disease 96 (28.4) 92 (33.2)
Two-vessel disease 69 (20.4) 61 (22.0)
Three-vessel disease or left main 151 (44.7) 96 (34.7)
Site of coronary lesion, n (%)
Right coronary artery 26 (7.7) 15 (5.4)
0.2081Left anterior descending artery or Left circumflex artery 108 (31.9) 99 (35.7)
Both 180 (53.2) 134 (48.4)
Therapy strategy, n (%)
Conservative 127 (37.6) 109 (39.3)
0.47746Invasive PCI 198 (58.6) 162 (58.5)
Invasive CABG 13 (3.8) 6 (2.2)
PCI Revascularization therapy
NO 140 (41.4) 115 (41.5)
0.38162PCI on Right Coronary Artery 132 (39.0) 26 (9.4)PCI on Left Coronary Artery 132 (39.0) 111 (40.1)
PCI on Both 22 (6.6) 25 (9.0)
PCI with stent implantation (≤ 2) 172 (83.5) 144 (87.3) 0.3089
Stent Implanted, n (%)
BMS 87 (25.7) 79 (28.5) 0.4396
DES 110 (32.5) 81 (29.2) 0.3785
Management STEMI, n (%)
Primary PCI for STEMI 26 (76.5) 27 (61.4) 0.11797Rescue PCI for STEMI 8 (23.5) 17 (38.6)
Table 2: Procedural data of patients with Acute Coronary Syndrome 
(n=615) according to sex.
BMS: bare metal stent; CABG: Coronary Artery Bypass Graft; DES: 





Epicardial Coronary angiographic data, n (%)
Normal 109 (21.8) 63 (20.6)
0.6625One-vessel disease 156 (31.3) 90 (29.4)Two-vessel disease 87 (17.4) 64 (20.9)
Three-vessel disease or left main 147 (29.5) 89 (29.1)
Site of coronary lesion, n (%)
Right coronary artery 41 (8.2) 16 (5.2)
0.26647Left anterior descending artery or Left circumflex artery 160 (32.1) 94 (30.7)
Both 187 (37.5) 131 (42.8)
Therapy strategy, n (%)
Conservative 249 (49.9) 169 (55.2)
0.04902Invasive PCI 223 (44.5) 130 (42.5)
Invasive CABG 28 (5.6) 7 (2.3)
Revascularization therapy, n (%)
PCI on Right Coronary Artery 44 (19.7) 23 (17.7)
0.62359PCI on Left Coronary Artery 160 (71.7) 91 (70.0)
PCI on Both 19 (8.6) 16 (12.3)
PCI with stent implantation (≤ 2), n 
(%) 202 (87) 114 (86) 0.7148
Stent Implanted, n (%)
BMS 75 (15.0) 43 (14.5) 0.7034
DES 147 (29.4) 86 (28.1) 0.6808
Table 3: Procedural data of patients with Stable Angina (n=805) according 
to sex
BMS: bare metal stent; CABG: Coronary Artery Bypass Graft; DES: 
drug-eluting stent; PCI: percutaneous coronary intervention; STEMI: ST 
elevation myocardial infarction.





Age, mean ± SD 82.8 ± 2.6 83.6 ± 3.0 <0.0001
Age classes, n (%)
80-84 years 648 (77.4) 395 (67.7)
0.0002185-89 years 170 (20.3) 165 (28.3)
≥ 90 years 19 (2.3) 23 (4.0)
BMI, (kg/m2) mean ± SD 25.8 ± 3.4 25.9 ± 4.4 0.662711
BSA, (m2) mean ± SD 1.83 ± 0,14 1.66 ± 0.15 <0.001
Vascular Access, n (%)
Radial 546 (65.2) 353 (60.6)
0.11989Femoral 249 (31.1) 199 (34.1)
From radial to femoral 31 (3.7) 31 (5.3)
Familial history of CVD, n (%) 201 (24.0) 156 (26.8) 0.24102
Hypertension, n (%) 558 (66.7) 429 (73.6) 0.00534
Smoking Habit, n (%) 543 (64.9) 102 (17.5) <0.00001
Diabetes, n (%) 222 (26.5) 198 (34.0) 0.00252
Treatment of diabetes, n (%) N=222 N=198
Diet 25 (11.3) 14 (7.1)
0.1574Oral 135 (60.8) 114 (57.6)
Insulin 57 (25.7) 68 (34.3)
Combined 5 (2.2) 2 (1.0)
Dyslipidemia, n (%) 309 (36.9) 245 (42.0) 0.05230
CKD§, n (%) 143 (17.1) 81 (13.9) 0.10461
Concomitant Valvulopathy, n (%) 39 (4.7) 48 (8.2) 0.00574
Type of valvulopathy
Aortic insufficiency 3 (0.4) 4 (0.7)
0.04260Aortic Stenosis 27 (3.2) 27 (4.7)
Mitral insufficiency 9 (1.1) 16 (2.8)
Combined 0 (0.0) 1 (0.2)
Access to cath. lab, n (%)
SA 499 (59.6) 306 (52.5)
0.00397UA 158 (18.9) 109 (18.8)
NSTEMI 146 (17.4) 124 (21.3)
STEMI 34 (4.1) 44 (7.6)
Timing of PCI, n (%)
Primary for STEMI 55 (6.5) 51 (8.7)
0.00340
Rescue for STEMI 8 (1.0) 17 (2.9)
Early invasive for NSTEMI/UA 275 (32.9) 209 (35.9)
Elective for SA 499 (59.6) 306 (52.5)
Previous MI, n (%) 124 (14.8) 70 (12.0) 0.5250
BMI: body mass index; BSA: body surface area; CKD: chronic kidney 
disease; CVD: cardiovascular disease; MI: myocardial infarction; NSTEMI: 
no ST elevation myocardial infarction; PCI: percutaneous coronary 
interventions; UA: unstable angina; SA: stable angina; STEMI: ST elevation 
myocardial infarction;
§CKD defined by creatinine levels ≥ 1.5 mg/dl.
All-cause mortality: On Cox proportional hazard analysis male sex 
[Hazard Ratio (HR)= 1.24, 95% Confidence Interval (CI): 1.03-1.48, p= 
0.020], age more than 85 years (HR=1.38, 95% CI: 1.09-1.76, p=0.006), 
presence of diabetes (HR=1.33, 95% CI:1.10-1.59, p=0.002), treated 
dyslipidemia (HR=0.80, 95% CI:0.77-0.96, p=0.019), CKD (HR=1.43, 
95% CI:1.15-1.78, p=0.001), concomitant valvular disease (HR=1.51, 
95% CI:1.08-2.11, p=0.014), myocardial infarction clinical presentation 
(HR=1.32, 95% CI:1.09-1.61, p=0.004), are independent predictors of 
overall mortality in a model adjusted for nutritional state, vascular femoral 
access, familiar history of CVD, smoking, treated hypertension, extension 
of coronary vessel lesions, invasive therapy strategy and CKD.
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Sex female, n (%) 386 (42.6) 197 (38.3) 0.11530
Age, years, mean ± SD 83.1 ± 2.7 83.1 ± 2.9 0.86446
Age classes, n (%)
≤ 85 years 748 (83.6) 427 (83.0)
0.8057
>85 years 158 (17.4) 87 (17.0)
BMI, (kg/m2) mean ± SD 25.8 ± 3.9 25.7 ± 3.8 0.31345
Abnormal nutritional State, n (%) 589 (65.0) 309 (60.1) 0.06603
BSA, (m2) mean ± SD 1.76 ± 0,17 1.76 ± 0.17 0.9922
Femoral Vascular Access, n (%) 281 (31.0) 240 (46.7) <0.0001
Familial history of CVD, n (%) 236 (26.0) 121 (23.5) 0.29519
Hypertension, n (%) 649 (71.6) 338 (65.8) 0.02084
Smoking Habit, n (%) 401 (44.3) 244 (47.5) 0.24295
Diabetes, n (%) 242 (26.7) 168 (34.6) 0.00168
Dyslipidemia, n (%) 374 (41.3) 180 (35.0) 0.02011
CKD§, n (%) 125 (13.8) 99 (19.3) 0.00664
Reasons for angiography, n (%)
Stable Angina 533 (59) 272 (53)
0.03073
Acute Coronary syndrome 373 (41) 242 (47)
Coronary vessel lesions
Normal epicardial arteries or non-occlusive disease 168 (18.5) 54 (10.5)
<0.0001
One-vessel disease 307 (33.9) 127 (24.7)
Two-vessel disease 174 (19.2) 107 (20.8)
Three-vessel disease or left main 257 (28.4) 226 (44.0)
Invasive PCI, n (%) 476 (52.5) 237(46.1) 0.01987
Conservative therapy, n (%) 403 (44.5) 252 (49.0) 0.09865
Previous MI, n (%) 140 (15.4) 107 (20.8) 0.01038
Table 4: Baseline Characteristics According to Survival
BMI: body mass index; BSA:  body surface area; CKD: chronic kidney disease; CVD: cardiovascular disease; MI:  myocardial infarction; NSTEMI: no 
ST elevation myocardial infarction; PCI: percutaneous coronary interventions; UA: unstable angina; SA: stable angina; STEMI: ST elevation myocardial 
infarction; 
§CKD defined by creatinine levels ≥ 1.5 mg/dl.
 
SEX (Female= blue line; Male=green Line)
Figure 1: Kaplan-Meier curves according to sex for all-cause death (panel A) and cardiac death (panel B)
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 AGE (<=85= blue line; >85=green Line
Figure 2: All-cause death (panel A) and cardiac death (panel B) according to age cut-off of 85 years
 
 
Strategy therapy (Conservative= blue line; Invasive=green Line)
Figure 3: Kaplan-Meier curves according to Treatment Strategy (i.e. conservative vs. intensive) for all-cause death (Panel A) and cardiac death (Panel B).
Cardiac death: On Cox proportional hazard analysis male sex (HR 
1.20, 95% CI:1.00-1.46, p=0.050], age more than 85 years (HR=1.43, 
95% CI: 1.13-1.81, p=0.003), presence of diabetes (HR=1.36, 95% 
CI:1.12-1.64, p=0.002), treated dyslipidemia (HR=0.87, 95% CI:0.65-
0.95, p=0.016), CKD (HR=1.40, 95% CI:1.11-1.76, p=0.004), myocardial 
infarction clinical presentation (HR=1.32, 95% CI:1.09-1.61, p=0.004), 
are independent predictors of cardiac death in a model adjusted for 
nutritional state, vascular femoral access, concomitant valvular disease 
familiar history of CVD, smoking, treated hypertension, extension of 
coronary vessel lesions, invasive therapy strategy and CKD.
Discussion
The major findings of this study, including a large unselected cohort 
of very elderly patients, all underwent diagnostic coronary angiography 
followed by elective or primary interventions, are the following: first, 
compared with men, women presenting with symptoms of myocardial 
ischemia are older, have a higher rate of traditional risk factors and account 
for an increased number and proportion of primary PCIs. Second, despite 
these heavier risk factors burden, reperfusion in women was associated 
with a better outcome at follow-up. However, a dilution of the efficacy 
occurred with increasing age and associated comorbidities, and for male 
patients, the benefit of the invasive strategy was not clear. Third, although 
in the setting of the stable angina conservative strategy was the more 
frequent option women had, no sex differences in all-cause mortality and 
cardiac death were observed over the follow-up. Fourth, no sex disparities 
in antiplatelet therapy were detected with most patients (80%) with stent 
treated with aspirin and clopidogrel. Moreover, the long median follow-up 
allowed us to evaluate the safety profile of long standing medical therapy, 
specifically clopidogrel, and its role in preventing adverse cardiac events 
in the very elderly population. Finally, no significant sex differences in 
the burden of obstructive epicardial disease were observed in both ACS 
and SA patients. In 52% (ACS, n=371; SA, n=366) of patients, PCI with 
implantation of one or more stents were performed. Thus, the results of 
the present study point out the challenge of managing elderly population 
presenting with myocardial ischemia.
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In the next years, along with chronological increase of the population, 
very elderly patients will more likely be female, more often with a high rate 
of risk factors, heavier comorbidities, and presenting later in the course of 
IHD than male counterparts [8].
During the last years, elderly patients have experienced considerable 
improvements in in-hospital outcomes and these improvements were 
accompanied by increases in the use of reperfusion therapies. Despite 
that, women have continued to experience a worse prognosis as compared 
to men [2,9].
Such female vulnerability, in apparent contrast with widely reported 
lesser extent of epicardial coronary involvement, has been related to 
gender differences in clinical presentation, comorbidities, and treatment 
strategies [10].
Globally, studies conducted largely in men documented a reduction in 
the risk of adverse cardiac events with a routine interventional strategy. 
Nevertheless, they suggest the existence of a possible gender difference 
in the occurrence and extent of benefit of myocardial reperfusion, with 
a worse outcome in women population.  In OASIS 5 women sub-study, a 
higher risk of mortality at 1-year with an early invasive strategy has been 
reported. This harm was mainly driven by a higher risk of major bleeding 
at 30-days with an early invasive strategy [11].
In the ISACS-TC registry [12], 2225 STEMI patients’ ≥ 70 years old 
(72.8% were ≥ 70 to 79 years old and 27.2% were ≥ 80 years old) were 
admitted into the network. Primary PCI decreased the unadjusted risk of 
death both in the elderly (OR: 0.32, 95% CI: 0.24-0.43) and very elderly 
patients (OR: 0.45, 95% CI 0.30-0.68), without significant difference 
between groups. The rate of death was two times greater for those patients 
who did not receive reperfusion. Of note, among others female gender was 
the only independent factor associated with the lack of use of reperfusion 
in both groups confirming that sex disparities in treatment persist in the 
older female population.
The AMIS Plus project [13] by analyzing temporal trends in the 
treatment and outcomes of older patients with ACS, documented that 
this cohort of patients has considerable improvements in short-term 
in-hospital outcomes by increasing the use of guideline-recommended 
therapies. Furthermore, the increased PCI use was not associated 
with lower effectiveness to prevent in-hospital death, despite its use in 
increasingly older (i.e. septua-, octo-, and nonagenarians) and co-morbid 
patients.
Taken together, these findings suggested that reperfusion therapy by 
PCI, along with recommended more effective drugs, in old patients are 
beneficial, leading to reduced risk mortality. In our study, conservative 
and invasive strategies were associated with a similar long-term survival 
for both sexes over the time. Of note, a trend in the better prognosis in 
terms of survival of the female group has been observed. Nevertheless, 
the benefits seem to be reduced with increasing age. Kaplan-Meier curves 
analysis showed that very elderly patients had a higher risk for occurrence 
of cardiac death (Log-rank: 7.91, p=0.005), and all-cause death (Log-
rank: 5.51, p<0.001) compared to patients with less than 85 years old. On 
multivariable analysis, several co-morbidities were found significantly 
related to older patients and might contribute to the worse outcome. 
Of notice, although men with stable angina underwent more frequently 
elective PCI, in our cohort of patients the benefit of such invasive approach 
was not evident since the analysis was run considering the CAD severity 
and the strategy of revascularization regardless sex. 
The After Eighty study [14] was the first randomized controlled trial to 
be specifically designed for the very elderly population with NSTEMI and 
unstable angina, which are frequent causes of hospital admission in this 
age group. The Authors documented that invasive strategy is superior to a 
conservative one in terms of a composite outcome including myocardial 
infarction, need for urgent revascularization, stroke, and death. However, 
a dilution of the efficacy occurred with increasing age, and for patients 
older than 90 years the benefit of the invasive strategy was not clear. 
Importantly, no specific therapeutic interventions are addressed to elderly 
women making the results of that trial less conclusive for such population.
More recently, the impact of an early invasive strategy on in-hospital 
survival, as compared with an initial conservative strategy, has been 
evaluated exclusively in women with the non-ST-elevation acute coronary 
syndrome in a real-world scenario. The results of that study confirmed the 
in-hospital mortality benefit of an early invasive strategy in women with 
non-ST-elevation myocardial infarction and high-risk features [15].
It should be noted, though data is specifically targeted to women, that 
a large proportion of enrolled patients aged less than 65 years. Thus, it is 
difficult to translate those results to the older population.
Importantly, in our analysis of contemporary real‐life data, we enrolled 
all consecutive male and female patients, aged 80 years or older, with 
suspected IHD and angiographic definition of coronary involvement. So, 
the strength of the present study includes a large number of very elderly 
women (41%) from real world scenario powered enough to assess whether 
sex and gender differences exist in the management of stable and acute 
coronary syndromes and in the outcome at a long follow-up.
Thus, we may hypothesize that treatment strategy and clinical variable 
rather than biological gender disparities might have a pivotal role in 
affecting clinical outcomes.
Limitations
Despite clinical benefit offered by recommended treatment strategies, 
mortality rate is high in the present cohort. It is conceivable that the effects 
of advancing age itself, including morphological changes with blunted 
cardiac function, increase the risk of mortality in older patients [16].
In the present study, data regarding cardiac functional parameters 
are lacking and it may determine a confounding effect on estimation of 
factors predicting mortality.
Therefore, presenting symptoms and time from symptom onset to 
reperfusion were not recorded. Elderly patients often present with atypical 
symptoms, causing delay in diagnosis and effective treatment. It results 
in a worse pre-intervention hemodynamic status that causes higher 
mortality rates [17,18].
In addition, biochemical markers of periprocedural injury were not 
assessed. Noteworthy, a meta-analysis from 20 studies over 19-year 
period, showed a significant correlation between increased mortality and 
troponin elevation after elective PCI [19].
Finally, no angiographic indexes of myocardial reperfusion enter the 
statistical analysis. Elderly patients are more likely to have a lower post-
procedural myocardial perfusion grade resulting in a reduced ventricular 
functional recovery that adversely affects the outcome [20,21].
Conclusions
The increasing proportion of elderly in the general population is 
expected to continue over the next years, suggesting that the need for 
managing older patients will continue to increase. Our data support the 
evidence that an invasive strategy including optimal medical treatment 
along with percutaneous interventions reduces the mortality rate by 
offering a similar survival improvement for both sexes. Furthermore, the 
benefit remains unchanged with increasing age. However, these findings 
must be interpreted with caution and further studies addressed to elderly 
women are needed to evaluate the relative merits of available reperfusion 
strategies as well as newer antithrombotic adjunctive therapies.
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